AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
83 hedge funds and large institutions have $37.3M invested in AVEO Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
60% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 25
Holders
83
Holding in Top 10
–
Calls
$3.86M
Puts
$1.37M
Top Buyers
1 | +$672K | |
2 | +$565K | |
3 | +$230K | |
4 |
WA
WealthTrust Axiom
Wayne,
Pennsylvania
|
+$90K |
5 |
ARTA
A.R.T. Advisors
New York
|
+$85K |
Top Sellers
1 | -$4.01M | |
2 | -$3M | |
3 | -$554K | |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$435K |
5 |
FI
Fosun International
Hong Kong,
China
|
-$335K |